No connection

Search Results

Earnings Score 85 Bullish

Eli Lilly Shares Surge as Q1 Earnings Crush Estimates

Apr 30, 2026 15:18 UTC
LLY
Short term

Eli Lilly reported a massive beat on both top and bottom lines, driven by GLP-1 demand and rapid growth in its oncology pipeline. The company's stock jumped 8.7% following the release of its first-quarter results.

  • Non-GAAP EPS of $8.55 vs $6.97 expected
  • Quarterly revenue of $19.8 billion vs $17.6 billion expected
  • Revenue grew 56% YoY; profits surged 170% YoY
  • Shipment volumes rose 65% despite a 13% drop in pricing
  • Oncology and neuroscience divisions grew by 160%
  • Progress reported on FDA approval for oral GLP-1 pill Foundayo

Eli Lilly (NYSE: LLY) shares climbed 8.7% on Thursday after the pharmaceutical giant reported first-quarter results that significantly exceeded Wall Street expectations. The company posted non-GAAP earnings of $8.55 per share, comfortably beating the analyst consensus of $6.97, while quarterly sales reached $19.8 billion against an expected $17.6 billion. Financial performance was bolstered by the company's GLP-1 portfolio, which drove a 56% year-over-year increase in revenue. Profits grew even more aggressively, rising 170% compared to the previous year. While shipment volumes increased by 65%, the company noted a 13% decline in pricing, reflecting intensifying competition within the obesity and diabetes drug market. Beyond its weight-loss success, Lilly is aggressively diversifying its revenue streams to reduce reliance on GLP-1 medications. The company's immunology, oncology, and neuroscience divisions saw growth of 160% during the quarter. This strategic pivot is being supported by a series of recent acquisitions of gene therapy companies. Looking forward, the company highlighted continued progress toward FDA approval for Foundayo (orforglipron), its oral GLP-1 pill. The combination of strong core growth and a rapidly expanding cancer treatment business led the company to raise its forward guidance, fueling the positive market reaction.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Related Articles

Score 62 Bullish

Royal Caribbean Shares Surge Following Q1 Earnings Beat and Guidance Hike

Apr 30, 17:09

Score 65

Industrial Strength Lifts Dow as AI Capex Concerns Weigh on Big Tech

Apr 30, 17:08

Score 48 Bearish

Choice Hotels Shares Plunge Following Profit Miss and Weak FY26 Guidance

Apr 30, 17:01

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI Chat
Markets
Profile